These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
36 related articles for article (PubMed ID: 1483496)
1. Pharmacokinetics of famotidine in goats after intravenous administration. Escher OG; Smith JS; Christopher K; Hogan B; Harvill LE; Hopson M; Cox S J Vet Pharmacol Ther; 2024 May; ():. PubMed ID: 38720597 [TBL] [Abstract][Full Text] [Related]
2. Hepatitis following famotidine: a case report. Gupta N; Patel C; Panda M Cases J; 2009 Jan; 2(1):89. PubMed ID: 19173722 [TBL] [Abstract][Full Text] [Related]
3. Drug administration in chronic liver disease. Westphal JF; Brogard JM Drug Saf; 1997 Jul; 17(1):47-73. PubMed ID: 9258630 [TBL] [Abstract][Full Text] [Related]
4. Clinical pharmacokinetic and pharmacodynamic considerations in patients with liver disease. An update. Morgan DJ; McLean AJ Clin Pharmacokinet; 1995 Nov; 29(5):370-91. PubMed ID: 8582120 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics of famotidine in patients with cirrhosis and ascites. Vinçon G; Baldit C; Couzigou P; Demotes-Mainard F; Elouaer-Blanc L; Bannwarth B; Begaud B Eur J Clin Pharmacol; 1992; 43(5):559-62. PubMed ID: 1483496 [TBL] [Abstract][Full Text] [Related]
8. Famotidine pharmacokinetics following oral and intravenous administration in patients with liver disease: results of a preliminary study. Morgan MY; Stambuk D Postgrad Med J; 1986; 62 Suppl 2():29-37. PubMed ID: 2890149 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of famotidine in normal subjects and in patients with chronic liver disease. Morgan MY; Stambuk D; Cottrell J; Mann SG Aliment Pharmacol Ther; 1990 Feb; 4(1):83-96. PubMed ID: 2104076 [TBL] [Abstract][Full Text] [Related]
10. Pharmacokinetics and bioavailability of famotidine in 10 Chinese healthy volunteers. Gao S; Liu GL; Wang SX; Gao XH Zhongguo Yao Li Xue Bao; 1991 May; 12(3):195-8. PubMed ID: 1781278 [TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of famotidine after intravenous administration in liver disease. Ohnishi K Am J Gastroenterol; 1991 Jan; 86(1):41-5. PubMed ID: 1986553 [TBL] [Abstract][Full Text] [Related]
14. 24 hour intragastric acidity and single night-time dose of three H-2-blockers. Dammann HG; Müller P; Simon B Lancet; 1983 Nov; 2(8358):1078. PubMed ID: 6138616 [No Abstract] [Full Text] [Related]
15. [Pharmacokinetics of intravenous ranitidine and its effect on gastric acid secretion stimulated by pentagastrin in the cirrhotic]. Bretagne JF; Reymann JM; Tassou JJ; Allain H; Gosselin A; Gastard J Gastroenterol Clin Biol; 1983 Apr; 7(4):355-61. PubMed ID: 6135641 [TBL] [Abstract][Full Text] [Related]